SABRINA GREENE: Open Payments
NPI 1629760319 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$937 in 45 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $2,604 · 2025 $937
Food & beverage: $937
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $289 |
| PFIZER INC. | 13 | $182 |
| UCB, Inc. | 5 | $119 |
| Lilly USA, LLC | 3 | $73 |
| Janssen Biotech, Inc. | 2 | $71 |
| Amgen Inc. | 3 | $62 |
| SOBI, INC | 2 | $41 |
| Genentech USA, Inc. | 1 | $36 |
| TerSera Therapeutics LLC | 1 | $33 |
| Ferring Pharmaceuticals Inc. | 1 | $32 |
Products named: RINVOQ, XELJANZ, Bimzelx, SKYRIZI, TALTZ, TREMFYA, OCTAGAM IMMUNE GLOBULIN (HUMAN), TAVNEOS.
Industry payments across FL — which companies pay providers there.
